Estrigenix Therapeutics closed the first tranche of its $2M Series Seed round, led by Talents Fund I, securing early funding to advance its ERβ platform for women's health.
Estrigenix Therapeutics closed the first tranche of its $2M Series Seed round, led by Talents Fund I, securing early funding to advance its ERβ platform for women's health.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
